SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/beta-catenin signaling. Xu M, Song X, Kudusi, Zu X, et al. BMC Med Genomics 2026;19:165.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu M, Song X, Kudusi, Zu X, et al. SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/beta-catenin signaling. BMC Med Genomics 2026;19:165.
PMID: 42958250